(Q40625823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

Apostolia Maria Tsimberidou

4 November 2019

main subject

phase II clinical trial

0 references

author

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Fernando Cabanillas

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A H Sarris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Hagemeister

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Romaguera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M A Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P McLaughlin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L J Medeiros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B Samuels

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

O Pate

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Oholendt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Kantarjian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Burge

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

69-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

The binding of vincristine, vinblastine and colchicine to tubulin.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Twenty years of MOPP therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Phase I study of liposomal vincristine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348010437

7 January 2021

Identifiers

DOI

10.1023/A:1008348010437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690390%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference